Acura gets $200k more loans from AD Pharma; warns cash may run out by mid-July 2025

ACURA PHARMACEUTICALS, INC

Principal balance on AD Pharma secured note now $8,194,279; accrued interest ~$721k.
Two new $100k loans received June 3 and June 20, 2025; interest at 5.25% (7.5% default).
AD Pharma, which owns 65% of Acura's common stock, is the lender; controlled by Mr. Schutte.
Without additional financing by mid-July 2025, Acura may furlough/lay off employees or seek bankruptcy protection.
Company states no assurance additional financing will be obtained; proceeds used for day-to-day operations.

item 1.01item 2.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.